Cutera (NASDAQ:CUTR) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Cutera (NASDAQ:CUTR) in a research report sent to investors on Tuesday morning. The brokerage issued a sell rating on the medical device company’s stock.

Cutera Trading Down 4.9 %

Shares of CUTR opened at $0.44 on Tuesday. The firm has a market capitalization of $8.96 million, a P/E ratio of -0.07 and a beta of 1.31. Cutera has a 12-month low of $0.28 and a 12-month high of $3.18. The firm has a fifty day moving average price of $0.39 and a 200-day moving average price of $0.71.

Cutera (NASDAQ:CUTR) last issued its earnings results on Thursday, November 7th. The medical device company reported ($1.94) EPS for the quarter, missing analysts’ consensus estimates of ($0.96) by ($0.98). The firm had revenue of $32.50 million for the quarter, compared to analyst estimates of $32.57 million. During the same quarter in the previous year, the business posted ($2.22) earnings per share. Analysts predict that Cutera will post -5.78 earnings per share for the current year.

Institutional Trading of Cutera

An institutional investor recently raised its position in Cutera stock. Squarepoint Ops LLC grew its stake in Cutera, Inc. (NASDAQ:CUTR) by 164.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 113,964 shares of the medical device company’s stock after acquiring an additional 70,870 shares during the quarter. Squarepoint Ops LLC owned about 0.57% of Cutera worth $172,000 at the end of the most recent quarter. Institutional investors and hedge funds own 90.70% of the company’s stock.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.